The pathophysiological interaction between hypertension and dyslipidemia, which includes oxidative stress, proinflammatory activities, renin–angiotensin–aldosterone system activation, and endothelial dysfunction, has been supported by accumulating evidence (42). This evidence concerns the gene REN and endothelial dysfunction.